National HealthCare Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	1,453	1,252	1,088	1,029	965.54	931.8
Other Revenue	47.33	46.18	47.7	45.2	45.4	46.13
Revenue	1,501	1,298	1,135	1,074	1,011	977.93
Revenue Growth (YoY)	22.67%	14.32%	5.68%	6.26%	3.38%	-1.85%
Cost of Revenue	922.16	810.93	712.34	686.17	666.06	605.77
Gross Profit	578.46	487.01	422.97	388.11	344.88	372.16
Selling, General & Admin	45.42	43.18	41.53	40.98	40.82	40.49
Other Operating Expenses	364.3	321.39	288.18	289.37	266.75	275.16
Operating Expenses	454.31	406.56	371.74	370.84	348.24	357.67
Operating Income	124.15	80.45	51.23	17.27	-3.37	14.49
Interest Expense	-7.9	-4.14	-0.32	-0.56	-0.85	-1.4
Interest & Investment Income	18.18	18.08	14.65	10.66	11.62	13.99
Earnings From Equity Investments	0.51	0.59	2.02	0.48	5.11	12.34
EBT Excluding Unusual Items	134.94	94.98	67.56	27.85	12.52	39.42
Gain (Loss) on Sale of Investments	1.42	30.96	14.94	-15.81	82.38	-22.06
Gain (Loss) on Sale of Assets	-	1.02	6.23	-	-	2.78
Asset Writedown	-	-	-	-	-8.23	-
Other Unusual Items	-	9.45	-	15.19	63.36	32.28
Pretax Income	136.36	136.41	88.74	27.23	150.04	52.42
Income Tax Expense	32.92	34.32	23.45	7.25	10.95	10.43
Earnings From Continuing Operations	103.44	102.09	65.29	19.98	139.09	41.99
Minority Interest in Earnings	-2.19	-0.16	1.51	2.47	-0.5	-0.12
Net Income	101.25	101.93	66.8	22.45	138.59	41.87
Net Income to Common	101.25	101.93	66.8	22.45	138.59	41.87
Net Income Growth	-18.52%	52.59%	197.61%	-83.80%	230.99%	-38.62%
Shares Outstanding (Basic)	15	15	15	15	15	15
Shares Outstanding (Diluted)	16	16	15	15	15	15
Shares Change (YoY)	0.43%	1.44%	-0.45%	0.20%	0.31%	0.06%
EPS (Basic)	6.55	6.62	4.36	1.46	9.03	2.74
EPS (Diluted)	6.48	6.53	4.34	1.45	8.99	2.72
EPS Growth	-18.78%	50.46%	199.31%	-83.87%	230.51%	-38.74%
Free Cash Flow	146.86	79.7	83.32	-21.46	23	181.39
Free Cash Flow Per Share	9.40	5.11	5.42	-1.39	1.49	11.80
Dividend Per Share	2.500	2.420	2.340	2.260	2.110	2.080
Dividend Growth	4.17%	3.42%	3.54%	7.11%	1.44%	0.97%
Gross Margin	38.55%	37.52%	37.26%	36.13%	34.12%	38.06%
Operating Margin	8.27%	6.20%	4.51%	1.61%	-0.33%	1.48%
Profit Margin	6.75%	7.85%	5.88%	2.09%	13.71%	4.28%
Free Cash Flow Margin	9.79%	6.14%	7.34%	-2.00%	2.27%	18.55%
EBITDA	168.74	122.44	93.26	57.76	37.31	56.51
EBITDA Margin	11.24%	9.43%	8.21%	5.38%	3.69%	5.78%
D&A For EBITDA	44.59	41.99	42.03	40.49	40.67	42.02
EBIT	124.15	80.45	51.23	17.27	-3.37	14.49
EBIT Margin	8.27%	6.20%	4.51%	1.61%	-0.33%	1.48%
Effective Tax Rate	24.14%	25.16%	26.43%	26.64%	7.30%	19.90%
Revenue as Reported	1,501	1,307	1,142	1,086	1,074	1,028

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q